CompletedNot Applicable

Pathologic-MRI Findings in Atypical IIDD

25 participantsStarted 2017-01-01

Plain-language summary

Our objective is to describe the pathologic and MRI findings in a series of patients with presumed demyelinating lesion of the central nervous system.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Presence of brain lesion in MRI suggestive of demyelinating lesions * Biopsy analysis revealed active inflammation with active demyelination * No known diagnosis of MS or Devic's disease or other diagnosis Exclusion Criteria: \- NO

What they're measuring

pathological

Timeframe: 1 day

Trial details

NCT IDNCT03121105

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-12-01

View on ClinicalTrials.gov More Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System trials